Hardware · AI News ·
Bristol Myers Squibb buys Nvidia AI system for drug discovery
Bristol Myers Squibb is purchasing an Nvidia DGX SuperPOD based on the company’s Vera Rubin architecture for AI use in drug discovery and development. The pharmaceutical company said it will be the first life sciences group to acquire a Vera Rubin-based DGX SuperPOD.